(MED 301) NEOPLASIA AND HEMATOPOIETIC SYSTEMS DISEASES COMMITTEE (4 WEEK) CODE DISCIPLINE THEORETIC AL
|
|
|
- Elaine Ford
- 5 years ago
- Views:
Transcription
1 OKAN UNIVERSITY FACULTY OF MEDICINE ACADEMIC YEAR PHASE III COMMITTEE I (MED 301) NEOPLASIA AND HEMATOPOIETIC SYSTEMS DISEASES COMMITTEE (4 WEEK) CODE DISCIPLINE THEORETIC AL PRACTIC AL MED301 1-CLINICAL BIOCHEMISTRY 6 6 TOTAL MED301 2-MEDICAL PHARMACOLOGY MED301 3-MEDICAL ONCOLOGY MED301 4-PATHOLOGY MED PEDIATRICS MED301 6-GENETICS 6 6 MED RADIATION ONCOLOGY 5 5 MED CHEST SURGERY 2 2 MED301 9-NUCLEAR MEDICINE 4 4 MED EAR, NOSE AND THROAT 2 2 MEDICAL LECTURES TOTAL HOURS OTHER COURSE 10-HAPPY LIFE 6 6 TOTAL DEAN COORDINATOR IN CHIEF COORDINATOR OF PHASE III ASSISTANT COORDINATOR : Prof. Dr. Semih BASKAN : Prof. Dr. A. Demet KAYA : Prof. Dr. Okan BÖLÜKBAŞI : Assist. Prof. Dr. Nermin BÖLÜKBAŞI
2 LIST OF PARTICIPANTS IN THE SUBJECT COMMITTEE DEPARTMENTS LECTURERS 1- CLINICAL BIOCHEMISTRY Prof. Murat BOLAYIRLI 2- MEDICAL PHARMACOLOGY BÖLÜKBAŞI 3- MEDICAL ONCOLOGY Assist. Prof. Sinemis ÇELİK 4-PATHOLOGY 5- PEDIATRICS Dr. Özben Yalçın Prof. Emin ÜNÜVAR Assist. Prof. Şenol Bozdağ 6- GENETICS Assist. Prof. Hakan BERKIL 7- RADIATION ONCOLOGY Prof. Metin GUDEN Assist. Prof. Tayfun Hancılar 8- CHEST SURGERY Prof. Muzaffer METIN 9- NUCLEAR MEDICINE Prof. Kerim SÖNMEZOĞLU 10- EAR, NOSE AND THROAT Prof. İsmail Koçak
3 MEDICINE PHASE III MED301-WEEK Opening ceremony Pathology; Neoplasia: Nomenclature Dr. Özben Yalçın Pathology; Benign and malignant tumors Dr. Özben Yalçın Pathology; Karsinogenesis, Patology of Karsinogenesis Dr. Özben Yalçın Pathology; Patology of Metastasis Dr. Özben Yalçın Pediatrics; Child Patient Approach Prof. Emin Unuvar Pediatrics; Anamnesis in pediatric patients Prof. Emin Unuvar Pediatrics; Evaluation of the skin and subcutaneous tissue Prof. Emin Unuvar Medical Oncology; The pathophysiology of cancer Assist. Prof. Sinemis ÇELİK Medical Oncology; Bone marrow failure tables Assist. Prof. Sinemis ÇELİK Medical Oncology; Plasma cell disease Assist. Prof. Sinemis ÇELİK Pediatrics; Neonatal examination Assist. Prof. Şenol Bozdağ Pediatrics; Newborn screening tests Assist. Prof. Şenol Bozdağ Perşembe / Thursday Medical Oncology; Adult Patient Approach Assist. Prof. Sinemis ÇELİK Medical Oncology;Anamnesis in Adult patients Assist. Prof. Sinemis ÇELİK Cuma / Friday Pediatrics; Head, face and eye examination Prof. Emin Unuvar
4 Pediatrics; Ear, nose and throat examination Prof. Emin Unuvar Perşembe / Thursday Medical Oncology; Acute Leukemia Assist. Prof. Sinemis ÇELİK Medical Oncology; Lymphocytosis and CLL Assist. Prof. Sinemis ÇELİK Happy Life Happy Life MED301-WEEK Genetics; Overview of chromosomal disorders Assist. Prof. Hakan Berkil Genetics; Overview of single gene disorders Assist. Prof. Hakan Berkil Pediatrics; Risk Newborn and Newborn care Assist. Prof. Şenol Bozdağ Pediatrics; Newborn Jaundice Assist. Prof. Şenol Bozdağ Medical Oncology; Chronic myeloproliferative neoplasms Assist. Prof. Sinemis ÇELİK Medical Oncology; Chronic myeloproliferative neoplasms Assist. Prof. Sinemis ÇELİK Genetics; The most common genetic diseases Assist. Prof. Hakan Berkil Genetics; The genetic basis of cancer Assist. Prof. Hakan Berkil Medical pharmacology: General Principles of Cancer Chemotherapy Medical pharmacology: General Principles of Cancer Chemotherapy Radiation Oncology; Clinical Radiation oncology physics Prof. Metin Güden Radiation Oncology; Head and neck cancers Prof. Metin Güden Radiation Oncology; Leukemias and lymphomas Prof. Metin Güden Radiation Oncology; Childhood cancers Prof. Metin Güden Pediatrics; Clinical assessment of growt and development Prof. Emin Unuvar Pediatrics; Clinical assessment of growt and development Prof. Emin Unuvar Nuclear Medicine; Basic principles of scintigraphic imaging Prof. Kerim Sonmezoglu Nuclear Medicine; Basic principles of radionuclide treatments Prof. Kerim Sonmezoglu Medical Oncology;Lymphomas Assist. Prof. Sinemis ÇELİK Medical Oncology; Lymphomas Assist. Prof. Sinemis ÇELİK Medical pharmacology: Anticancer drugs Medical pharmacology: Anticancer drugs Genetics; Oncogenes and tumor suppressor genes Assist. Prof. Hakan Berkil Genetics; Cancer gene pathways, cancer genom and genetic -12. instability,genetic alterations in common cancer Clinical Biochemistry; Circulating tumor markers : Basic concepts and clinical applications Clinical Biochemistry; Circulating tumor markers : Basic concepts -15. and clinical applications Assist. Prof. Hakan Berkil Prof. Murat Bolayırlı Prof. Murat Bolayırlı
5 Cuma / Friday Radiation Oncology; Lung Carcinoma Assist. Prof. Tayfun Hancılar Pediatrics; Evaluation of superficial lymph node Prof. Emin Unuvar Pediatrics; Hematologic System Inspection, Peripheral Smear Evaluation Happy life Happy life Prof. Emin Unuvar Perşembe / Thursday MED301-WEEK Pathology; Introductıon to Lymph node Pathology Dr. Özben Yalçın Pathology; Lymphadenitis Dr. Özben Yalçın Pathology; Neoplastic Proliferations of White Cells: Hodgkin Disease Pathology; Neoplastic Proliferations of White Cells: Non-Hodgkin Disease Dr. Özben Yalçın Dr. Özben Yalçın Pediatrics; Hematologic and oncologic patient approach Prof. Emin Unuvar Pediatrics; Anemia approach Prof. Emin Unuvar Medical Oncology; Normocytic anemia Assist. Prof. Sinemis ÇELİK Medical Oncology; Microcytic Anemia Assist. Prof. Sinemis ÇELİK Pathology; Bone marrow pathology Dr. Özben Yalçın Pathology; Spleen and Thymus Dr. Özben Yalçın Pathology lab; Dr. Özben Yalçın Pathology lab; Dr. Özben Yalçın Medical pharmacology: Anticancer drugs Medical pharmacology: Anticancer drugs Ear, Nose and Throat; Head and Neck Tumours Prof. İsmail Koçak Ear, Nose and Throat; Head and Neck Tumours Prof. İsmail Koçak Pediatrics; Hepato- splenomegaly Prof. Emin Unuvar Pediatrics; Jaundice Prof. Emin Unuvar Nuclear Medicine; Nuclear oncology-conventional scintigraphy Prof. Kerim Sonmezoglu Nuclear Medicine; Nuclear oncology-positron Emission Tomography Prof. Kerim Sonmezoglu Medical Oncology; Macrocytic anemia Assist. Prof. Sinemis ÇELİK Medical Oncology; Hemostasis disorders Assist. Prof. Sinemis ÇELİK Clinical Biochemistry; Hemoglobinopathies and thalassemias Prof. Murat Bolayırlı Clinical Biochemistry; Hemoglobinopathies and thalassemias Prof. Murat Bolayırlı Clinical Biochemistry; Biochemical aspects of anemia Prof. Murat Bolayırlı
6 Cuma / Friday Clinical Biochemistry; Biochemical aspects of anemia Prof. Murat Bolayırlı Medical Pharmacology: Immunosuppressants Medical Pharmacology: Immunosuppressants Medical Oncology; Thrombocytopenia and platelet function disorders. Assist. Prof. Sinemis ÇELİK Medical Oncology; Blood products and transfusion Assist. Prof. Sinemis ÇELİK Chest Surgery; Introduction to lung cancers Prof. Muzaffer Metin Chest Surgery; Introduction to lung cancers Prof. Muzaffer Metin Pediatrics; Iron deficiency anemia Prof. Emin Unuvar Pediatrics; Common coagulation disorders in pediatrics Prof. Emin Unuvar Medical Pharmacology: Drugs for Anemia Medical Pharmacology: Drugs for Anemia Happy life Happy life MED301-WEEK4
7 Perşembe / Thursday Cuma / Friday Theoretical Exam- Practical Exam
(MED 307) GASTROINTESTINAL SYSTEM DISEASES COMMITTEE (4 WEEK)
OKAN UNIVERSITY FACULTY OF MEDICINE 2016 2017 ACADEMIC YEAR PHASE III COMMITTEE IV (MED 307) GASTROINTESTINAL SYSTEM DISEASES COMMITTEE 11.12.2016-05.01.2018 (4 WEEK) CODE DISCIPLINE THEORETICAL PRACTICAL
OKAN UNIVERSITY FACULTY OF MEDICINE ACADEMIC YEAR PHASE III COMMITTEE II
OKAN UNIVERSITY FACULTY OF MEDICINE 2017 2018 ACADEMIC YEAR PHASE III COMMITTEE II (MED303) MICROORGANISM AND THEIR DISEASES COMMITTEE 4 WEEK PROGRAMME (09.10.2017-03.11.2017) SUMMARY OF THE COMMITTEE-II
(MED 302) UROGENITAL and ENDOCRINE SYSTEM DISEASES COMMITTEE (6 WEEK)
OKAN UNIVERSITY FACULTY OF MEDICINE 2017 2018 ACADEMIC YEAR PHASE III COMMITTEE V (MED 302) UROGENITAL and ENDOCRINE SYSTEM DISEASES COMMITTEE 22.01.2018-02.03.2018 (6 WEEK) CODE DISCIPLINE THEORETICAL
CODE DISCIPLINE THEORETICAL PRACTICAL TOTAL 1-ANESTHESIOLOGY AND REANIMATION
ISTANBUL OKAN UNIVERSITY FACULTY OF MEDICINE 2018 2019 ACADEMIC YEAR PHASE III COMMITTEE III MED 305 CARDIOVASCULAR AND RESPIRATORY SYSTEM DISEASES COMMITTEE 12.11.2018-14.12.2018 (5 WEEK) CODE DISCIPLINE
CODE DISCIPLINE THEORETICAL PRACTICAL TOTAL 1-CLINICAL BIOCHEMISTRY
ISTANBUL OKAN UNIVERSITY FACULTY OF MEDICINE 2018 2019 ACADEMIC YEAR PHASE III COMMITTEE IV MED 307 GASTROINTESTINAL SYSTEM DISEASES COMMITTEE 17.12.2018-11.01.2019 (4 WEEK) CODE DISCIPLINE THEORETICAL
Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology
Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Faculty representative: Neil Weiner, MD Resident representative: Guiherme Rabinowits, MD Revision date: February 28, 2006 Goals
YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY
1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor
LIST OF PARTICIPANTS IN THE SUBJECT COMMITTEE
OKAN UNIVERSITY FACULTY OF MEDICINE 2016 2017 ACADEMIC YEAR PHASE II COMMITTEE III ENDOCRINE & UROGENITAL SYSTEM COMMITTEE (MED 202) 5 WEEK PROGRAMME (22.01.2018 23.02.2018) SUMMARY OF THE COMMITTEE-III
SUMMARY OF THE COMMITTEE-II
OKAN UNIVERSITY FACULTY OF MEDICINE 2019 ACADEMIC YEAR PHASE I BASIC SCIENCES SUBJECT COMMITTEE-II (MED 103) 7 WEEK PROGRAMME (12.11. 28.12.) SUMMARY OF THE COMMITTEE-II DISCIPLINE THEORETICAL PRACTICAL
GASTROINTESTINAL SYSTEM AND METABOLISM COMMITTEE (MED203) 8 WEEK PROGRAMME ( )
OKAN UNIVERSITY FACULTY OF MEDICINE 2018 2019 ACADEMIC YEAR PHASE II COMMITTEE II GASTROINTESTINAL SYSTEM AND METABOLISM COMMITTEE (MED203) 8 WEEK PROGRAMME (05.11.2018 28.12.2018) SUMMARY OF THE COMMITTEE
ENDOCRINE & UROGENITAL SYSTEM COMMITTEE (MED202) 5 WEEK PROGRAMME ( )
OKAN UNIVERSITY FACULTY OF MEDICINE 2018 2019 ACADEMIC YEAR PHASE II COMMITTEE III ENDOCRINE & UROGENITAL SYSTEM COMMITTEE (MED202) 5 WEEK PROGRAMME (28.01.2019 01.03.2019) SUMMARY OF THE COMMITTEE-III
ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology
ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME approved: June 27, 2006; effective: July 1, 2007 ACGME approved focused revision: September 30, 2012; effective:
OKAN UNIVERSITY FACULTY OF MEDICINE ACADEMIC YEAR PHASE III COMMITTEE VII
OKAN UNIVERSITY FACULTY OF MEDICINE 2017 2018 ACADEMIC YEAR PHASE III COMMITTEE VII (MED 306) PUBLIC HEALTH, FORENSIC MEDICINE and MEDICAL ETHICS SUBJECT 23.04.2017-18.05.2017 (4 WEEK) CODE DISCIPLINE
Diseases Of The Blood
Diseases Of The Blood DR. Associate Professor Of Pathology Faculty Of Medicine Ain Shams University Red Blood Cells and Anemia RBC=4-6 million/mm 2 Hb=12-18 g/dl Oxygen Carrying Molecule Hemoglobin Tetramer:
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423
12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization
Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,
Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED
Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Acute Myeloid Leukemia Firstly we ll start with this introduction then enter the title of the lecture, so be ready and let s begin by the name of Allah : We
Course Outline: Blood and Immunology. DRAFT 14 May 2013
Course Outline: Blood and Immunology DRAFT 14 May 2013 What we need to decide What do medical students need to learn about Hematology and Immunology? What knowledge/skills does an undifferentiated physician
2. Occupancy rate of beds in the hospital: Occupancy rate of at least 60%
Appendix A Training Centre Accreditation Checklist A. Accreditation of the HOSPITAL 1. Total number of beds in the hospital : Minimum 500 beds 2. Occupancy rate of beds in the hospital: Occupancy rate
STUDY GUIDE. At the end of the module, the students should be able to: Outcomes
Module Title Introduction Hematology STUDY GUIDE This Hematology module hinges on the previous Blood module taught in semester 2. This module will focus on the abnormal aspects of Blood. It will deal with
CARDIOVASCULAR AND RESPIRATORY SYSTEM COMMITTEE (MED201) 7 WEEK PROGRAMME ( )
OKAN UNIVERSITY FACULTY OF MEDICINE 2018 2019 ACADEMIC YEAR PHASE II COMMITTEE I CARDIOVASCULAR AND RESPIRATORY SYSTEM COMMITTEE (MED201) 7 WEEK PROGRAMME (17.09.2018 02.11.2018) SUMMARY OF THE COMMITTEE
HEMATOLOGY MODULE STUDY GUIDE Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf
HEMATOLOGY MODULE STUDY GUIDE A Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf C Course Committee Dr. Irfan Ashraf, Dr. Syeda Zarreen Raza, Dr. Rubia Kashif D Objectives of Study
Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center
MEDICAL ONCOLOGY AND HEMATOLOGY (R2, R3) A. The PURPOSE of this rotation is to afford medical residents a broad clinical and training experience in the clinical diagnosis and management of common adult
July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244
July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for
CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009
LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of
PEDIATRIC HEMATOLOGY/ONCOLOGY ROTATION
DEPARTMENT OF PEDIATRICS NATIONAL CAPITAL CONSORTIUM PEDIATRIC RESIDENCY PROGRAM PEDIATRIC HEMATOLOGY/ONCOLOGY ROTATION February 2017 1. DURATION OF ROTATION: One (1) block/four (4) weeks. 2. ELIGIBILITY:
QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS
QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS WHAT IS TRUE AND WHAT IS FALSE? Questions 1 Iron deficiency anemia a) Is usually associated with a raised MCV. b) The MCH is usually low. c) Is most commonly due
VA Hematology/Oncology Elective
VA Hematology/Oncology Elective The Medical Oncology and Hematology section at the Syracuse VA Medical Center is responsible for providing specialized care to our veterans with cancer and blood disorders.
CASPER COLLEGE MLTK 1500 HI Clinical Hematology and Hemostasis. Lecture Hours: 2 Lab Hours: 4 Credit Hours: 3
Semester/Year: Fall 2015 CASPER COLLEGE MLTK 1500 HI Clinical Hematology and Hemostasis Lecture Hours: 2 Lab Hours: 4 Credit Hours: 3 Class Time: Lecture Moodle Student Labs: Friday 12-5: 9/11 9/25 10/23
Care of the Patient with a Blood or Lymphatic Disorder. ph Volume pints. Red blood cells (RBC) White blood cells (WBC)
Slide 1 Chapter 7 Care of the Patient with a Blood or Lymphatic Disorder 1 Slide 1 Overview of Anatomy and Physiology Characteristics of blood Consistency (viscous) 45% blood cells RBC WBC Platelets 55%
BIOLOGY 2290 Pathophysiology I (Health Sciences III ) Sept 2010 Instructor : Dr. Paul S. Sunga, Rm A359a, , Introduction
BIOLOGY 2290 Pathophysiology I (Health Sciences III ) Sept 2010 Instructor : Dr. Paul S. Sunga, Rm A359a, 323-5251, psunga@langara.bc.ca Introduction This course is designed to provide students with insights
Lymphatic System Disorders
Lymphatic System Disorders Lymphomas Malignant neoplasms involving lymphocyte proliferation in lymph nodes Specific causes not identified // Higher risk in adults who received radiation during childhood
Myelodyplastic Syndromes Paul J. Shami, M.D.
Myelodyplastic Syndromes Paul J. Shami, M.D. Professor of Hematology, University of Utah Member, Huntsman Cancer Institute Objectives Define Myelodysplastic Syndromes (MDS) Explain how MDS are diagnosed
(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2
ก ก. ก ก.. ก (anemia) ก hemoglobin concentration, hematocrit ก ก ก 2 Standard deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2 Hemoglobin hematocrit MCV (g/dl) (%) (fl) ( ) 0.5-1.9
General Pathology Theory Syllabus for II B.D.S.
General Pathology Theory Syllabus for II B.D.S. Sr. No. Topic (Must Know) (Desirable to know) 1.Introduction to Pathology - Different sections in pathology - The Cell in health - Normal cell structure
Hematology/Oncology/BMT
The University of Arizona Pediatric Residency Program Primary Goals for Rotation Hematology/Oncology/BMT 1. GOAL: Understand the role of the pediatrician in preventing hematologic or oncologic conditions,
Hematological diseases
Hematological diseases Today we will talk about signs and symptoms of Hematology. Signs vs. Symptoms what s the difference? Symptom: is what the patient complains from, OR its what the patient tells you
The Evaluation and Classification of Anemia
Case studies and research for better care To refer a patient, call. The Evaluation and Classification of Anemia A diagnostic approach BY AMANDA BRANDOW, DO, MS Anemia is defined as hemoglobin concentration
Pathology of Hematopoietic and Lymphoid tissue
Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph
CELL-MEDIATED IMMUNITY
LECTURE #4 1 LYMPHATIC SYSTEM 2 CELL-MEDIATED IMMUNITY T-lymphocytes (activated in the thymus) identify aggressors and try to destroy them through the production of lymphokines (synthesized proteins) Killer
Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology
Neoplasia Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology General Considerations Overview: Neoplasia uncontrolled,
University of Michigan Health System Internal Medicine Residency. Hematology/Oncology Curriculum: University Hospital Hematology Consultation Service
University of Michigan Health System Internal Medicine Residency Hematology/Oncology Curriculum: University Hospital Hematology Consultation Service Version date: 12/16/2009 Subspecialty Education Coordinator:
Saint James School of Medicine
1 Saint James School of Medicine COURSE: GENERAL PATHOLOGY CLASS: MDIII SEMESTER: Spring (Jan-Apr, 2013) COORDINATOR: Associate Professor Dr. Reza Farhour Email: rfarhour@mail.sjsm.org COURSE DESCRIPTION:
155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.
SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE- Total hours number 70 hours, including course 0 hours, seminars 0 hours. Aim of the subject of Hematology: The study of etiology, pathogenesis,
The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:
Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist
Infections and nonmicrobial inflammatory stimuli can cause leukocytosis (as seen in Lab 1) as well as lymph node enlargement (lymphadenopathy).
LAB 5: LYMPHOID TISSUE AND SKIN The focus of this week s lab will be pathology of the lymphoid tissue and skin. The lymphoid organs include the thymus, spleen, and lymph nodes. Abnormalities in the lymph
UNMH Hematology/Oncology Clinical Privileges
o Initial privileges (initial appointment) o Renewal of privileges (reappointment) o Expansion of privileges (modification) All new applicants must meet the following requirements as approved by the UNMH
1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease
Hematology/Oncology Description: The pediatric hematology-oncology division sees a wide spectrum of pediatric disease including but not limited to leukemia, hemophilia, solid tumors, ITP, and other blood
Al-Balqa Applied University Faculty of Medicine
Al-Balqa Applied University Faculty of Medicine Course Title: Blood and Lymphatic System (BLS). Course Code: 31500371 Credit Hours: 4 Credits Calendar Description: 4 weeks/ sem.2/ year 2 Teaching approaches:
Regions Hospital Delineation of Privileges Internal Medicine Hematology / Oncology
Regions Hospital Delineation of Privileges Internal Medicine Hematology / Oncology Applicant s Name: Last First M. Instructions: Place a check-mark where indicated for each core group you are requesting.
Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases)
Table 8.1. Epidemiology of Leukemia in the United States (2010) Type of Leukemia Annual Incidence (Number of New Cases) Percentage of All Leukemias (%) Annual Deaths Mean Age Acute lymphocytic 5,330 12
Pediatric Hematology-Oncology
Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS
Hematology Page 1 of 8
Hematology Page 1 of 8 Hematology Major Category Code Headings Revised 12/17 1 Basic methodology and test armamentarium 20000 2 Normal hematopoiesis & hemostasis 20100 3 RBC disorders, non-neoplastic 20340
Pathology of Hematopoietic and Lymphoid tissue
CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis
Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC
Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing
Classification of Hematologic Malignancies. Patricia Aoun MD MPH
Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences
Electrocardiography Gönenç Kocabay Electrocardiography Gönenç Kocabay Electrocardiography Gönenç Kocabay
Phase III Comm. 3 Nov 14, 2016 09.00-09.50 Approach to the Respiratory Tract Infections Aslı KARADENİZ Monday 10.00-10.50 Nasal and sinus diseases Öner ÇELİK 11.00-11.50 Diseases of pharynx and larynx
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable
CHRONIC LYMPHOCYTIC LEUKEMIA
CHRONIC LYMPHOCYTIC LEUKEMIA This medical guide is designed for educational purposes to help patients understand. Please consult your doctor on specific questions and details about your symptoms. 02 03
Symptoms and Signs in Hematology/ 2013
Symptoms and Signs in Hematology/ 2013 Abdallah Abbadi.MD.FRCP Professor of Hematology & Oncology University of Jordan & JUH Email: abdalla.awidi@gmail.com Diseases of Blood & Blood forming organs A- Benign
MYELODYSPLASTIC AND MYELOPROLIFERATIVE
MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISORDERS Pediatric Hemato-Oncology Division Medical Faculty University of Sumatera Utara 1 MYELODYSPLASIA SYNDROME A group of disorder defect in hematopoetic cell
Microcytic Hypochromic Anemia An Approach to Diagnosis
Microcytic Hypochromic Anemia An Approach to Diagnosis Decreased hemoglobin synthesis gives rise to microcytic hypochromic anemias. Hypochromic anemias are characterized by normal cellular proliferation
DEPARTMENT OF CLINICAL HEMATOLOGY
DEPARTMENT OF CLINICAL HEMATOLOGY What is blood? Blood is the vital fluid of the body, which performs diverse functions from delivering oxygen to each and every cell of the body to fighting against infections
Latest Press Release. Celexa italiano
corp@stantec.com Latest Press Release Celexa italiano S Chronic Lymphocytic Leukemia. Overview. Chronic lymphocytic leukemia (CLL) is a slowgrowing cancer of the blood that develops when the bone marrow
Index. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug
WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD
WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features
Melanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
Chapter 46. Care of the Patient with a Blood or Lymphatic Disorder
Chapter 46 Care of the Patient with a Blood or Lymphatic Disorder All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Components of the Blood Red
Culture Advantage. Anatomy and Medical Terminology for Interpreters ONCOLOGY TERMINOLOGY
1 Culture Advantage Anatomy and Medical Terminology for Interpreters ONCOLOGY TERMINOLOGY Marlene V. Obermeyer, MA, RN marlene@culture-advantage.com 2 Oncology Case Study for the PowerPoint Presentation
Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident
Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Residents: Pediatric residents at the PL3 level Prerequisites: Successful completion or waiver
Clinical Privileges Profile Hematology/Oncology. Kettering Medical Center System
Printed Name Clinical Privileges Profile Hematology/Oncology Kettering Medical Center Sycamore Medical Center Kettering Medical Center System Applicant: Check off the Requested box for each privilege requested.
Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89
Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Presented by Jennifer Kurkulonis 1 FOUR MAJOR TYPES OF BLOOD CELLS White blood cells
SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN
SICKLE CELL DISEASE Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Objective: The student should be able: To identify the presentation, diagnosis,
Disorders of Blood Cells & Blood Coagulation
Disorders of Blood Cells & Blood Coagulation HIHIM 409 WBC count RBC count WBC differential Hemoglobin (HGB) Hematocrit (HCT) % of volume occupied by RBCs CBC Red cell indices Mean cell volume (MCV) average
STUDY GUIDE. At the end of the module, students should be able to:
Module Title Introduction STUDY GUIDE Hematology This Hematology module hinges on the previous Blood module taught in semester 2. This module will focus on the abnormal aspects of Blood. It will deal with
Clinical & Laboratory Assessment
Clinical & Laboratory Assessment Dr Roger Pool NHLS & University of Pretoria Clinical Assessment (History) Anaemia ( haemoglobin) Dyspnoea (shortness of breath) Tiredness Angina Headache Clinical Assessment
BIT 120. Copy of Cancer/HIV Lecture
BIT 120 Copy of Cancer/HIV Lecture Cancer DEFINITION Any abnormal growth of cells that has malignant potential i.e.. Leukemia Uncontrolled mitosis in WBC Genetic disease caused by an accumulation of mutations
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Anemia(s), 412 426 categories in morphologic approach to, macrocytic, 412 414 microcytic, 412 414 normocytic, 412 413 categorizing, 412
Melanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
Squamous neck cancer survival rate
Squamous neck cancer survival rate The Borg System is 100 % Squamous neck cancer survival rate 15-2-2018 Cutaneous squamous cell carcinoma (cscc) is the second most common skin cancer and one of the most
PCCN Review Hematology
PCCN Review Hematology Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Anemia Definition reduction in RBC concentration Causes iron deficiency
Hematology Unit Lab 2 Review Material
Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after
REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable
The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)
The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,
Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias
Hematopoietic and Lymph Node Pathology Normal Development Red Blood Cell Maturation & Anemias Normal Development Differentiation of Hematopoietic Cells 1 Bone Marrow Bone Marrow Bone Marrow, RBC Precursors
PATHOLOGY & PATHOPHYSIOLOGY
PATHOLOGY & PATHOPHYSIOLOGY DISORDERS OF BLOOD DISORDERS OF BLOOD Disorders of Blood Infections Tumours Nutritional disorders Coagulation disorders Congenital disorders Septicaemia Leukemia Iron deficiency
Drop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College
Drop of Blood Unravels Mysteries Prof. Salma Afrose Department of Hematology Dhaka Medical College Peripheral Blood Film (PBF) PBF is a laboratory workup that involves cytology of Peripheral blood cell
Assessment and management of patients with hematologic disorder أ.م.د.وداد كامل محمد فرع تمريض البالغين
Assessment and management of patients with hematologic disorder أ.م.د.وداد كامل محمد فرع تمريض البالغين Assessment and management of patients with hematologic disorder The hematologic system consists of
Recommended Timing for Transplant Consultation
REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org
Reactive and Neoplastic Lymphocytosis
Reactive and Neoplastic Lymphocytosis Koranda A. Walsh, VMD, BS Assistant Professor, Clinical Pathobiology University of Pennsylvania School of Veterinary Medicine PLEASE NOTE: These notes are meant as
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood
Pathology of the Lymphoid System
Pathology of the Lymphoid System Learning Objectives: Define lymphadenitis and enumerate its types. Briefly describe the morphological appearance of reactive lymph node. Describe the microscopic picture
Hematologic changes in systemic diseases. Chittima Sirijerachai
Hematologic changes in systemic diseases Chittima Sirijerachai Systemic diseases Infection Renal diseases Liver diseases Connective tissue diseases Malignancy Anemia of chronic disease (ACD) Chronic infections:
Part II The Cell Cell Division, Chapter 2 Outline of class notes
Part II The Cell Cell Division, Chapter 2 Outline of class notes 1 Cellular Division Overview Types of Cell Division Chromosomal Number The Cell Cycle Mitoses Cancer Cells In Vitro Fertilization Infertility
Peripheral Blood Smear: Diagnostic Clues and Algorithms
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
Overview of Cutaneous Lymphomas: Diagnosis and Staging. Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology
Overview of Cutaneous Lymphomas: Diagnosis and Staging Lauren C. Pinter-Brown MD, FACP Health Sciences Professor of Medicine and Dermatology Definition of Lymphoma A cancer or malignancy that comes from
Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017
Overview of Aplastic Anemia Overview of Aplastic Anemia Peter Westervelt, MD, PhD Professor of Medicine Chief, BMT/Leukemia Section Washington University School of Medicine Epidemiology Normal hematopoiesis
California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar
Production Automation and Quality Control Unit Data Alert - Registrar 2015-061 REVISED Casefinding List FY2016 Please see additions and revisions noted below in red text. ICD-10-CM Codes have been adopted